• ERAD-Hijacking Chimeras Enable Targeted Degradation of TM Pr

  2026-06-30

  Song et al. developed ERAD-engaging chimeras (ERADECs), a small-molecule strategy that selectively degrades transmembrane (TM) proteins by hijacking the endoplasmic reticulum-associated degradation (ERAD) pathway. This innovation addresses long-standing obstacles in targeted protein degradation, broadening experimental and therapeutic options for membrane protein and immunology research.

• Optimizing DNA Repair Research with BMN 673 (Talazoparib) In

  2026-06-30

  This article provides an evidence-driven exploration of real laboratory challenges in DNA repair and cytotoxicity assays, demonstrating how BMN 673 (Talazoparib) Potent PARP1/2 Inhibitor (SKU A4153) from APExBIO offers reproducible, high-sensitivity solutions. Scenario-based Q&As address experimental design, protocol optimization, and product reliability, supporting biomedical researchers seeking robust tools for homologous recombination deficient cancer modeling.

• JNK-IN-7: Selective JNK Inhibitor for MAPK Pathway Research

  2026-06-29

  JNK-IN-7 is a highly selective JNK inhibitor with nanomolar potency, enabling precise modulation of c-Jun N-terminal kinase in apoptosis and innate immune signaling research. Its covalent mechanism and solubility profile make it suitable for advanced MAPK pathway studies. Evidence demonstrates its utility in dissecting Toll receptor and apoptosis pathways in cell-based models.

• NLRP10 Regulates Keratinocyte Survival and Barrier Function

  2026-06-29

  This study uncovers NLRP10 as a central regulator of epidermal homeostasis, promoting keratinocyte survival and P63-dependent differentiation to maintain skin barrier integrity in atopic dermatitis. The findings reveal mechanistic links between genetic variation at the NLRP10 locus and impaired skin barrier, highlighting NLRP10 as a promising therapeutic target.

• Trelagliptin Succinate Restores Chondrocyte Function via AMP

  2026-06-28

  The referenced study reveals that Trelagliptin succinate (SYR-472 succinate), a selective long-acting DPP-4 inhibitor, counteracts IL-1β-induced dysfunction in human chondrocytes by reactivating the AMPK/SOX-9 pathway. These findings introduce a novel mechanism for DPP-4 inhibitors in mitigating inflammation-driven cartilage degeneration, offering new avenues for research in osteoarthritis and diabetes comorbidity.

• Optimizing hiPSC Platelet Differentiation with Small Molecul

  2026-06-27

  This study presents a systematically optimized protocol for producing functional platelets from human induced pluripotent stem cells (hiPSCs), achieving higher yield and reduced costs by refining culture conditions and strategically applying small molecules. The approach addresses longstanding bottlenecks in ex vivo platelet generation and offers a scalable, cost-effective platform for translational research and therapeutic applications.

• Nystatin (Fungicidin): Optimizing Antifungal Assays in Resea

  2026-06-26

  Nystatin (Fungicidin) from APExBIO is a benchmark tool for dissecting fungal membrane integrity and resistance in Candida and Aspergillus research. This guide details evidence-based protocols, troubleshooting strategies, and advanced workflow integrations to maximize reproducibility and insight in antifungal studies.

• CTP Solution in High-Fidelity In Vitro Transcription Workflo

  2026-06-26

  CTP Solution (100 mM) empowers precise in vitro mRNA synthesis, enabling next-generation therapeutic and research applications. Its enzyme-free, high-purity formulation proves pivotal for reproducible results and sensitive downstream assays, as shown in recent mRNA-LNP cancer therapy breakthroughs.

• BRCA2 Prevents PARP1 Retention to Stabilize RAD51 Filaments

  2026-06-25

  This study uncovers a previously unknown role of BRCA2 in defending RAD51 filaments from destabilization by PARP1 retention during PARP inhibitor treatment. These findings clarify the mechanistic basis by which BRCA2 deficiency sensitizes tumors to PARP inhibition, refining research strategies for DNA repair targeting in homologous recombination deficient cancers.

• SP600125: Strategic JNK Inhibition for Translational Researc

  2026-06-25

  This article provides translational researchers with a mechanistically rich, strategically nuanced perspective on using SP600125—a selective JNK inhibitor—as a precision tool for dissecting inflammation and cytokine regulation. Integrating recent mechanistic insights, competitive context, and guidance on experimental best practices, we bridge foundational immunobiology with next-generation disease modeling. This piece builds beyond standard product descriptions by drawing on recent pathogenesis research and offering actionable strategies for maximizing the translational impact of JNK pathway modulation.

• Proteolytic Neuroligin 1 Fragments Sustain Social Memory via

  2026-06-24

  Liu et al. reveal that maintenance of social memory in mice depends on proteolytic fragments of neuroligin 1 generated by α- and γ-secretase activity following social interaction. This mechanism links extracellular signaling to sustained synaptic remodeling, offering new molecular insights into memory maintenance and potential targets for neuropsychiatric disorders.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-06-23

  This study elucidates how the yeast and hypha phases of Candida krusei induce apoptosis in bovine mammary epithelial cells (BMECs) via distinct mechanisms, implicating both mitochondrial and death receptor pathways. The findings clarify the involvement of TLR2/ERK and JNK/ERK signaling, offering mechanistic insights relevant to MAPK pathway and apoptosis research in veterinary mycology.

• Selective PDGFR Inhibition Prevents Pulmonary Vascular Remod

  2026-06-23

  This study introduces WQ-C-401, a highly selective PDGFR inhibitor, and demonstrates its efficacy in preventing pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension (PAH) in rats. The findings highlight the therapeutic potential of precise tyrosine kinase targeting for PAH, with implications for safer strategies compared to existing inhibitors like Imatinib (STI571).

• Cy3-UTP for RNA Labeling: Experimental Workflows & Optimizat

  2026-06-22

  Cy3-UTP enables ultra-bright, photostable labeling of RNA for advanced imaging and interaction assays. This guide distills best practices, troubleshooting insights, and strategic workflow enhancements that leverage Cy3-modified uridine triphosphate to drive discovery in RNA biology.

• BET Bromodomain Inhibitor (+)-JQ1: Precision Control in Epig

  2026-06-22

  Explore the scientific precision of Bromodomain Inhibitor, (+)-JQ1 in modulating chromatin function, KLF6-driven adipogenesis, and non-hormonal male contraception. This article uniquely analyzes super-enhancer targeting by JQ1, providing practical assay guidance for advanced epigenetic research.

16619 records 1/1108 page Next 12345 下5页 Last page